These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30113253)

  • 1. Vitamin D-binding protein and multiple sclerosis: Evidence, controversies, and needs.
    Gauzzi MC
    Mult Scler; 2018 Oct; 24(12):1526-1535. PubMed ID: 30113253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of vitamin D binding protein in multiple sclerosis.
    Disanto G; Ramagopalan SV; Para AE; Handunnetthi L
    J Neurol; 2011 Mar; 258(3):353-8. PubMed ID: 21042807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosis.
    Kułakowska A; Ciccarelli NJ; Wen Q; Mroczko B; Drozdowski W; Szmitkowski M; Janmey PA; Bucki R
    BMC Neurol; 2010 Nov; 10():107. PubMed ID: 21040581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D-binding protein in cerebrospinal fluid is associated with multiple sclerosis progression.
    Yang M; Qin Z; Zhu Y; Li Y; Qin Y; Jing Y; Liu S
    Mol Neurobiol; 2013 Jun; 47(3):946-56. PubMed ID: 23339019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free vitamin D
    Grut V; Biström M; Salzer J; Stridh P; Lindam A; Alonso-Magdalena L; Andersen O; Jons D; Gunnarsson M; Vrethem M; Hultdin J; Sundström P
    Eur J Neurol; 2022 Aug; 29(8):2335-2342. PubMed ID: 35582958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behind the scenes of vitamin D binding protein: more than vitamin D binding.
    Delanghe JR; Speeckaert R; Speeckaert MM
    Best Pract Res Clin Endocrinol Metab; 2015 Oct; 29(5):773-86. PubMed ID: 26522461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives on the vitamin D binding protein.
    Chun RF
    Cell Biochem Funct; 2012 Aug; 30(6):445-56. PubMed ID: 22528806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.
    Smolders J; Peelen E; Thewissen M; Menheere P; Damoiseaux J; Hupperts R
    Mult Scler; 2014 Apr; 20(4):433-7. PubMed ID: 23959712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2 vitamin D3.
    Shah AB; DiMartino SJ; Trujillo G; Kew RR
    Mol Immunol; 2006 Mar; 43(8):1109-15. PubMed ID: 16115686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D-binding protein gene polymorphisms are not associated with MS risk in an Italian cohort.
    Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Costa AS; Clerici M
    J Neuroimmunol; 2017 Apr; 305():92-95. PubMed ID: 28284354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and preliminary crystallographic characterization of the vitamin D sterol- and actin-binding by human vitamin D-binding protein.
    Swamy N; Head JF; Weitz D; Ray R
    Arch Biochem Biophys; 2002 Jun; 402(1):14-23. PubMed ID: 12051678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological implications of actin-free Gc-globulin concentration changes in blood plasma and cerebrospinal fluid collected from patients with Alzheimer's disease and other neurological disorders.
    Kułakowska A; Tarasiuk J; Kapica-Topczewska K; Chorąży M; Pogorzelski R; Kulczyńska-Przybik A; Mroczko B; Bucki R
    Adv Clin Exp Med; 2018 Aug; 27(8):1075-1080. PubMed ID: 29905407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multifunctional properties and characteristics of vitamin D-binding protein.
    White P; Cooke N
    Trends Endocrinol Metab; 2000 Oct; 11(8):320-7. PubMed ID: 10996527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D binding protein: a multifunctional protein of clinical importance.
    Speeckaert MM; Speeckaert R; van Geel N; Delanghe JR
    Adv Clin Chem; 2014; 63():1-57. PubMed ID: 24783350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D in autoimmune liver disease.
    Smyk DS; Orfanidou T; Invernizzi P; Bogdanos DP; Lenzi M
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):535-45. PubMed ID: 23845396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating levels of vitamin D binding protein in MS patients.
    Rinaldi AO; Sanseverino I; Purificato C; Cortese A; Mechelli R; Francisci S; Salvetti M; Millefiorini E; Gessani S; Gauzzi MC
    Toxins (Basel); 2015 Jan; 7(1):129-37. PubMed ID: 25590278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association of vitamin D-binding protein gene polymorphisms in Japanese patients with MS.
    Niino M; Kikuchi S; Fukazawa T; Yabe I; Tashiro K
    J Neuroimmunol; 2002 Jun; 127(1-2):177-9. PubMed ID: 12044990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyunsaturated fatty acids decrease the apparent affinity of vitamin D metabolites for human vitamin D-binding protein.
    Bouillon R; Xiang DZ; Convents R; Van Baelen H
    J Steroid Biochem Mol Biol; 1992 Sep; 42(8):855-61. PubMed ID: 1525046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D-binding protein as a biomarker to confirm specific clinical diagnoses.
    Lisowska-Myjak B; Jóźwiak-Kisielewska A; Łukaszkiewicz J; Skarżyńska E
    Expert Rev Mol Diagn; 2020 Jan; 20(1):49-56. PubMed ID: 31795772
    [No Abstract]   [Full Text] [Related]  

  • 20. Group-specific component is not only a vitamin-D-binding protein.
    Constans J
    Exp Clin Immunogenet; 1992; 9(3):161-75. PubMed ID: 1303095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.